JusticeNotableConfirmedDeveloping
10.0
Brazil's Cade recommends conviction of Bayer for anti-competitive practices
InfoMoney·BR·3 days ago
JusticeSingle-sourceMediumDeveloping
5.4
Novo Nordisk seeks US injunction against Eli Lilly weight-loss drug advertising
Novo Nordisk has filed for a preliminary injunction in a US court to halt Eli Lilly's marketing of weight-loss medications, alleging deceptive advertising practices. This legal action escalates an ongoing dispute between the two pharmaceutical firms over market dominance in the GLP-1 agonist sector.
Score Breakdown
Mosaic Score5.4
Confidence0.9
Significance0.5
Source credibility0.5
Intelligence Tags
Locations
United States
Entities
country
Related signals
8 foundMarketsNotableConfirmedDeveloping
10.0
Paramount pauses merger with Warner Bros. Discovery pending state-level litigation
Bluesky Journalist Feed·US·2 days ago
HealthNotableConfirmed
9.2
EU Commission approves weight-loss medication for obesity treatment
Die PresseLO·EU·3 days ago
HealthNotableSingle-sourceDeveloping
5.6
GLP-1 receptor agonist adoption trends and clinical implications in US healthcare
Al Jazeera·US·1 day ago
MarketsSingle-source
2.1
Fidson Healthcare reports 28% increase in half-year profit
Premium TimesLO·NG·2 days ago
HealthSingle-source
2.1
Hospital José Carrasco Arteaga secures one-year supply of multiple sclerosis medication
El UniversoLO·EC · NG·2 days ago
HealthSingle-source
2.1
São Paulo Court Denies Public Funding for Wegovy Weight-Loss Medication
Valor Econômico·BR·2 days ago
HealthSingle-source
2.1
ANMAT approves new oral therapy for psoriatic arthritis in Argentina
PerfilLO·AR·2 days ago